NEW YORK, March 13, 2018 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Obalon Therapeutics, Inc. (NASDAQ:OBLN) from October 5, 2016 through January 23, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Obalon investors under the federal securities laws.
To join the Obalon class action, go to http://rosenlegal.com/cases-1275.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, during the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Obalon recognized revenue in violation of Generally Accepted Accounting Principles; (2) Obalon lacked adequate internal controls over accounting and financial reporting; and (3) as a result, defendants’ statements about Obalon’s business, operations, and prospects were materially false and misleading at all relevant times.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 16, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1275.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates
Audi, SAIC Launch China Innovation Hub for New AUDI Models
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations
CATL Shares Fall as Hungary Plant Faces Safety Halt
Trump Secures Drug Pricing Deals With Nine Pharma Companies
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return
CIA-Linked Investor Helped Quantum Systems Expand in US
MediaTek Shares Jump 10% on Nvidia’s $3.5 Billion Investment
Shein Shares Drop 5% After Weak Hong Kong IPO Debut
OpenAI Rejects Apple Trade Secret Theft Claims
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 



